1	Abnormal	abnormal	_	_	_	_	_	_	_
2	apoptosis	apoptosis	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	cell	cell	_	_	_	_	_	_	_
5	cycle	cycle	_	_	_	_	_	_	_
6	progression	progression	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	humans	human	_	_	_	_	_	_	_
9	exposed	expose	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	methyl	methyl	_	_	_	_	_	_	_
12	tertiary-butyl	tertiary-butyl	_	_	_	_	_	_	_
13	ether	ether	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	benzene	benzene	_	_	_	_	_	_	_
16	contaminating	contaminating	_	_	_	_	_	_	_
17	water	water	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	1	1	_	_	_	_	_	_	_
2	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	we	we	_	_	_	_	_	_	_
5	hypothesized	hypothesize	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	individuals	individual	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	certain	certain	_	_	_	_	_	_	_
11	genetic	genetic	_	_	_	_	_	_	_
12	makeup	makeup	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	MTBE	MTBE	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	benzene	benzene	_	_	_	_	_	_	_
17	or	or	_	_	_	_	_	_	_
18	their	their	_	_	_	_	_	_	_
19	metabolites	metabolite	_	_	_	_	_	_	_
20	act	act	_	_	_	_	_	_	_
21	as	as	_	_	_	_	_	_	_
22	adducts	adduct	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	may	may	_	_	_	_	_	_	_
25	induce	induce	_	_	_	_	_	_	_
26	programmed	program	_	_	_	_	_	_	_
27	cell	cell	_	_	_	_	_	_	_
28	death	death	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	2	2	_	_	_	_	_	_	_
2	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	study	study	_	_	_	_	_	_	_
3	involved	involve	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	group	group	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	60	60	_	_	_	_	_	_	_
8	male	male	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	female	female	_	_	_	_	_	_	_
11	subjects	subject	_	_	_	_	_	_	_
12	who	who	_	_	_	_	_	_	_
13	were	be	_	_	_	_	_	_	_
14	exposed	expose	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	MTBE	mtbe	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	benzene-contaminated	benzene-contaminated	_	_	_	_	_	_	_
19	water	water	_	_	_	_	_	_	_
20	concentrations	concentration	_	_	_	_	_	_	_
21	up	up	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	76	76	_	_	_	_	_	_	_
24	PPB	ppb	_	_	_	_	_	_	_
25	for	for	_	_	_	_	_	_	_
26	MTBE	MTBE	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	14	14	_	_	_	_	_	_	_
29	PPB	ppb	_	_	_	_	_	_	_
30	for	for	_	_	_	_	_	_	_
31	benzene	benzene	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	for	for	_	_	_	_	_	_	_
34	a	a	_	_	_	_	_	_	_
35	period	period	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	5	5	_	_	_	_	_	_	_
38	to	to	_	_	_	_	_	_	_
39	8	8	_	_	_	_	_	_	_
40	years	year	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	For	for	_	_	_	_	_	_	_
2	comparison	comparison	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	we	we	_	_	_	_	_	_	_
5	recruited	recruit	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	control	control	_	_	_	_	_	_	_
8	group	group	_	_	_	_	_	_	_
9	consisting	consist	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	32	32	_	_	_	_	_	_	_
12	healthy	healthy	_	_	_	_	_	_	_
13	males	male	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	females	female	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	similar	similar	_	_	_	_	_	_	_
18	age	age	_	_	_	_	_	_	_
19	distribution	distribution	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	without	without	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	history	history	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	exposure	exposure	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	MTBE	mtbe	_	_	_	_	_	_	_
28	or	or	_	_	_	_	_	_	_
29	benzene	benzene	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	3	3	_	_	_	_	_	_	_
2	.	.	_	_	_	_	_	_	_

1	Peripheral	peripheral	_	_	_	_	_	_	_
2	blood	blood	_	_	_	_	_	_	_
3	lymphocytes	lymphocyte	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	PBL	PBL	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	both	both	_	_	_	_	_	_	_
9	groups	group	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	tested	test	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	percentage	percentage	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	apoptotic	apoptotic	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	cell	cell	_	_	_	_	_	_	_
20	cycle	cycle	_	_	_	_	_	_	_
21	progression	progression	_	_	_	_	_	_	_
22	using	use	_	_	_	_	_	_	_
23	flow	flow	_	_	_	_	_	_	_
24	cytometry	cytometry	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	4	4	_	_	_	_	_	_	_
2	.	.	_	_	_	_	_	_	_

1	When	when	_	_	_	_	_	_	_
2	apoptotic	apoptotic	_	_	_	_	_	_	_
3	lymphocytes	lymphocyte	_	_	_	_	_	_	_
4	from	from	_	_	_	_	_	_	_
5	exposed	expose	_	_	_	_	_	_	_
6	individuals	individual	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	compared	compare	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	apoptotic	apoptotic	_	_	_	_	_	_	_
11	lymphocytes	lymphocyte	_	_	_	_	_	_	_
12	from	from	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	control	control	_	_	_	_	_	_	_
15	group	group	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	statistically-significant	statistically-significant	_	_	_	_	_	_	_
18	differences	difference	_	_	_	_	_	_	_
19	between	between	_	_	_	_	_	_	_
20	each	each	_	_	_	_	_	_	_
21	mean	mean	_	_	_	_	_	_	_
22	group	group	_	_	_	_	_	_	_
23	were	be	_	_	_	_	_	_	_
24	detected	detect	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	26.4	26.4	_	_	_	_	_	_	_
27	+/-	+/-	_	_	_	_	_	_	_
28	1.8	1.8	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	12.1	12.1	_	_	_	_	_	_	_
31	+/-	+/-	_	_	_	_	_	_	_
32	1.3	1.3	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	respectively	respectively	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	indicating	indicate	_	_	_	_	_	_	_
38	an	an	_	_	_	_	_	_	_
39	increased	increase	_	_	_	_	_	_	_
40	rate	rate	_	_	_	_	_	_	_
41	of	of	_	_	_	_	_	_	_
42	apoptosis	apoptosis	_	_	_	_	_	_	_
43	in	in	_	_	_	_	_	_	_
44	80.5	80.5	_	_	_	_	_	_	_
45	%	%	_	_	_	_	_	_	_
46	of	of	_	_	_	_	_	_	_
47	exposed	expose	_	_	_	_	_	_	_
48	individuals	individual	_	_	_	_	_	_	_
49	(	(	_	_	_	_	_	_	_
50	P	p	_	_	_	_	_	_	_
51	<	<	_	_	_	_	_	_	_
52	0.0001	0.0001	_	_	_	_	_	_	_
53	,	,	_	_	_	_	_	_	_
54	Mann-Whitney	Mann-Whitney	_	_	_	_	_	_	_
55	U-Test	U-Test	_	_	_	_	_	_	_
56	)	)	_	_	_	_	_	_	_
57	.	.	_	_	_	_	_	_	_

1	MTBE	MTBE	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	benzene-induced	benzene-induced	_	_	_	_	_	_	_
4	apoptosis	apoptosis	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	attributed	attribute	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	discrete	discrete	_	_	_	_	_	_	_
10	block	block	_	_	_	_	_	_	_
11	within	within	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	cycle	cycle	_	_	_	_	_	_	_
15	progression	progression	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Because	because	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	cycle	cycle	_	_	_	_	_	_	_
4	analysis	analysis	_	_	_	_	_	_	_
5	showed	show	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	PBL	PBL	_	_	_	_	_	_	_
9	from	from	_	_	_	_	_	_	_
10	chemically-exposed	chemically-exposed	_	_	_	_	_	_	_
11	individuals	individual	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	between	between	_	_	_	_	_	_	_
14	20-50	20-50	_	_	_	_	_	_	_
15	%	%	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	were	be	_	_	_	_	_	_	_
19	accumulated	accumulate	_	_	_	_	_	_	_
20	at	at	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	S-G2/M	S-G2/M	_	_	_	_	_	_	_
23	boundaries	boundary	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	5	5	_	_	_	_	_	_	_
2	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	signaling	signal	_	_	_	_	_	_	_
5	molecules	molecule	_	_	_	_	_	_	_
6	which	which	_	_	_	_	_	_	_
7	mediates	mediate	_	_	_	_	_	_	_
8	programmed	program	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	death	death	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	nuclear	nuclear	_	_	_	_	_	_	_
13	factor	factor	_	_	_	_	_	_	_
14	Kappa-B	Kappa-B	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	NF-kappa	NF-kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	NF-kappa	NF-kappa	_	_	_	_	_	_	_
2	B	B	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	examined	examine	_	_	_	_	_	_	_
5	as	as	_	_	_	_	_	_	_
6	one	one	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	many	many	_	_	_	_	_	_	_
10	molecular	molecular	_	_	_	_	_	_	_
11	mechanisms	mechanism	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	mediating	mediate	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	death	death	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	MTBE	MTBE	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	benzene	benzene	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Indeed	indeed	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	addition	addition	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	inhibitors	inhibitor	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	pyrrolidine	pyrrolidine	_	_	_	_	_	_	_
11	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	PDTC	PDTC	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	lymphocytes	lymphocyte	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	chemically-exposed	chemically-exposed	_	_	_	_	_	_	_
22	group	group	_	_	_	_	_	_	_
23	was	be	_	_	_	_	_	_	_
24	capable	capable	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	inhibiting	inhibit	_	_	_	_	_	_	_
27	programmed	program	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	death	death	_	_	_	_	_	_	_
30	by	by	_	_	_	_	_	_	_
31	40	40	_	_	_	_	_	_	_
32	%	%	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	reversal	reversal	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	apoptosis	apoptosis	_	_	_	_	_	_	_
5	almost	almost	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	control	control	_	_	_	_	_	_	_
9	level	level	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	inhibitor	inhibitor	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	may	may	_	_	_	_	_	_	_
17	indicate	indicate	_	_	_	_	_	_	_
18	involvement	involvement	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	this	this	_	_	_	_	_	_	_
21	signaling	signal	_	_	_	_	_	_	_
22	molecule	molecule	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	MTBE	MTBE	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	benzene	benzene	_	_	_	_	_	_	_
27	induction	induction	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	programmed	program	_	_	_	_	_	_	_
30	cell	cell	_	_	_	_	_	_	_
31	death	death	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

